|

Paclitaxel and Cisplatin/ Carboplatin Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Shandong Cancer Hospital and Institute1

Indications

  • Neoplasm Recurrence, Local1
  • Oligometastatic1
  • Cervical Cancer1
  • Cancer1

Other1 trial

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.